Type I Interferon Induction in Cutaneous DNA Damage Syndromes

Area of Science:

• Immunology
• Genetics
• Dermatology

Background:

• Type I interferons (IFNs) are key antiviral cytokines activating innate and adaptive immunity via interferon-stimulated genes (ISGs).
• Constitutive type I IFN system activation is linked to autoinflammation and autoimmunity in systemic lupus erythematosus and monogenic interferonopathies, often due to mutations in nucleic acid sensing or DNA repair pathways.
• DNA damage can trigger type I IFN secretion through mechanisms like micronuclei formation and cytosolic DNA presence.

Purpose of the Study:

• To summarize mechanisms of type I IFN induction in hereditary cutaneous DNA damage syndromes.
• To review recent literature on DNA double-strand repair and nucleotide excision repair defects.
• To discuss the role of type I IFN in cancer and these specific genetic syndromes.

Main Methods:

• Literature review of recent publications.
• Focus on DNA repair defects in hereditary cutaneous DNA damage syndromes.
• Analysis of mechanisms linking DNA damage to type I IFN secretion.

Main Results:

• Hereditary cutaneous DNA damage syndromes share features with autoimmune disorders and interferonopathies.
• Defects in DNA repair pathways (e.g., Ataxia telangiectasia, Xeroderma pigmentosum) likely contribute to aberrant type I IFN secretion.
• The review synthesizes evidence for DNA-damage-induced type I IFN signaling in these conditions.

Conclusions:

• Aberrant type I IFN production is a plausible mechanism underlying the autoinflammatory and autoimmune features of cutaneous DNA damage syndromes.
• Understanding these pathways may offer insights into disease pathogenesis and potential therapeutic targets.
• Further research is needed to fully elucidate the role of type I IFNs in cancer and DNA repair disorders.